US2019000894A1PendingUtilityA1
Probiotic compositions and use thereof
Est. expiryDec 22, 2035(~9.4 yrs left)· nominal 20-yr term from priority
A61K 35/745A61K 35/747A61P 15/00Y02A50/30A61K 35/741A61P 31/04A61P 13/10A61P 15/02A61K 2300/00
30
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are probiotic compositions containing Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium animalis subsp. lactis. Such compositions are useful to prevent and/or treat urogenital infections in women by oral administration.
Claims
exact text as granted — not AI-modified1 . Probiotic composition for oral administration comprising:
Lactobacillus plantarum, Lactobacillus rhamnosus, and Bifidobacterium animalis subsp. lactis;
provided that the probiotic composition does not comprise a prebiotic component comprising at least one scFOS, short-chain fructo-oligosaccharide.
2 . Probiotic composition according to claim 1 , comprising the following strains:
Lactobacillus plantarum PBS067, Lactobacillus rhamnosus PBS070, and Bifidobacterium animalis subsp. lactis PBS075.
3 . Probiotic composition according to claim 1 , wherein Lactobacillus plantarum is present in amounts on the total weight of the composition ranging from 10 mg to 90 mg, preferably from 25 mg to 50 mg, more preferably is 33 mg.
4 . Probiotic composition according to claim 1 , wherein Lactobacillus rhamnosus is present in amounts on the total weight of the composition ranging from 10 mg to 90 mg, preferably from 25 mg to 50 mg, more preferably is 33 mg.
5 . Probiotic composition according to claim 1 , wherein Bifidobacterium animalis subsp. lactis is present in amounts on the total weight of the composition ranging from 10 mg to 90 mg, preferably from 25 mg to 50 mg, more preferably is 33 mg.
6 . Probiotic composition according to claim 1 , wherein Lactobacillus plantarum:Lactobacillus rhamnosus:Bifidobacterium animalis subsp. lactis are present in a ratio of 1:1:1.
7 . Probiotic composition comprising:
Lactobacillus plantarum, Lactobacillus rhamnosus, and Bifidobacterium animalis subsp. lactis,
for use in prevention and/or treatment of female urogenital infections and relapses thereof.
8 . Probiotic composition for use according to claim 7 , comprising the following strains:
Lactobacillus plantarum PBS067, Lactobacillus rhamnosus PBS070, and Bifidobacterium animalis subsp. lactis PBS075.
9 . Probiotic composition for use according to claim 7 , wherein Lactobacillus plantarum is present in amounts on the total weight of the composition ranging from 10 mg to 90 mg, preferably from 25 mg to 50 mg, more preferably is 33 mg.
10 . Probiotic composition for use according to claim 7 , wherein Lactobacillus rhamnosus is present in amounts on the total weight of the composition ranging from 10 mg to 90 mg, preferably from 25 mg to 50 mg, more preferably is 33 mg.
11 . Probiotic composition for use according to claim 7 , wherein Bifidobacterium animalis subsp. lactis is present in amounts on the total weight of the composition ranging from 10 mg to 90 mg, preferably from 25 mg to 50 mg, more preferably is 33 mg.
12 . Probiotic composition for use according to claim 7 , wherein Lactobacillus plantarum:Lactobacillus rhamnosus:Bifidobacterium animalis subsp. lactis are present in a ratio of 1:1:1.
13 . Probiotic composition for use according to claim 7 , wherein the female urogenital infection is bacterial vaginosis.
14 . Probiotic composition for use according to claim 7 , wherein the female urogenital infection is fungal vaginitis.
15 . Probiotic composition for use according to claim 7 , wherein the female urogenital infection is cystitis.
16 . Probiotic composition according to claim 2 , wherein Lactobacillus plantarum is present in amounts on the total weight of the composition ranging from 10 mg to 90 mg, preferably from 25 mg to 50 mg, more preferably is 33 mg.
17 . Probiotic composition according to claim 2 , wherein Lactobacillus rhamnosus is present in amounts on the total weight of the composition ranging from 10 mg to 90 mg, preferably from 25 mg to 50 mg, more preferably is 33 mg.
18 . Probiotic composition according to claim 2 , wherein Bifidobacterium animalis subsp. lactis is present in amounts on the total weight of the composition ranging from 10 mg to 90 mg, preferably from 25 mg to 50 mg, more preferably is 33 mg.
19 . Probiotic composition according to claim 2 , wherein Lactobacillus plantarum:Lactobacillus rhamnosus:Bifidobacterium animalis subsp. lactis are present in a ratio of 1:1:1.
20 . Probiotic composition according to claim 3 , wherein Lactobacillus plantarum:Lactobacillus rhamnosus:Bifidobacterium animalis subsp. lactis are present in a ratio of 1:1:1.Join the waitlist — get patent alerts
Track US2019000894A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.